A case of indolent systemic mastocytosis responding to treatment with Avapritinib
Key Clinical Message Low dose Avapritinib is a new medication that is a potential treatment option not just for advanced systemic mastocytosis, but also for the indolent form.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2024-02-01
|
| Schriftenreihe: | Clinical Case Reports |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/ccr3.8500 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|